Member Info for Ghia

Sharebel - I'm not doubting the tech here. I'm objecting to the links being made to article that is for a vaccine being trialed in Humans, which began development prior to any Covid Related announcement on this share. Pure manipulation of facts.

By the way I believe they used monkeys to get the linked vaccine all the way to trials so quickly.

Chrishar enjoy the rest of the ride with your remaining shares. By the way saw you over on ABDP a while back (apologies for the cross ramp) hold onto those they will serve you well long term.

Yes but the "breaking news link" was about a vaccine that is being tested in a trial on humans! Clearly not MICE so has no relevance to this share.

Hi All,

Considering making an entry here at some point does anyone know what the cash runway looks like here. Is there a potential dilutive funding on the horizon?

Appreciate any feedback from long term holders

LP it is part of the update to clinical trial documents dated yesterday.

If it works once approved this drug will be the first port of call to try against any new viral pathogens.

Plus the obvious COPD and Asthma applications.

Huge volume potential.

This share is not an investment whilst the pump and dump crew play with it. Good luck everyone

I have and there is nothing I can see that links this share with the vaccine being developed at oxford with AZN. And HEMO is not listed as a partner in that consortium.

Please provide proof otherwise and I will stand corrected.

Quoted 57.7p to sell

Mike - Exactly any data published will be torn to shreds if it's not accurate, it may take longer but our approach will generate the data we need. As others have mentioned this is why the new ACCORD trials are using our trial as the working model.

I think the bod are focused on the science not the share price and will release an RNS only when the science permits.

Trek curious will some of that capital be returning here in the morning?

Feel a bit gutted for you that this news was not in the form of an RNS.

It’s plausible although would you then expect them to stop the hospital trials altogether?

I’m not sure they will have analysed the data yet from the hospital trial though so perhaps this expansion was on the cards much earlier.

If they have analysed the data it could be that a strong placebo in the under 65 age range was against us and by moving to 65+age range the placebo is likely to be less strong.

These are just all thoughts

I think it shows that they think the product is safe. But we had a good indication of that anyway.

Certainly it’s a good sign.

Fair few care homes near me might have to print of a few copies of this article and pop them through the letter box.

Thanks Forest wonderful news

Hi Trek,

I didn't see many posts knocking your decision it's your investment and your rationale.

In the mean time if you spot any good research positive or negative send it our way.

And don't go blowing your fresh capital and some ropey pump and dump whilst you're away!

Good Luck

As of today I now own 0.035% of the company perhaps if we all club together we can release our own collective TR1 next week some news is better than no news!

Unfortunately the full 4285714 is below the 3% threshold so we may never find out.

Tomorrow is another day.